Global Uranium-230 Market Growth 2026-2032
The global Uranium-230 market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
In 2025, global Uranium-230 production was approximately 43 grams, with an average global market price of around $124,000 per gram. That year, total global production capacity for Uranium-230 reached 120 grams, and the industry's average gross profit margin stood at 35%. Uranium-230 is an artificial radioactive isotope of uranium with an atomic number of 92 and a mass number of 230. It has a half-life of approximately 20.8 days and primarily decays via alpha emission into thorium-226 (which has a half-life of about 30.6 minutes), subsequently releasing multiple alpha particles as it proceeds along the decay chain. Due to the high linear energy transfer and short tissue range of alpha particles, uranium-230 and its daughter isotope, thorium-226, are being investigated for targeted alpha therapy; they are particularly promising for treating micrometastases, residual lesions, and disseminated cancer cells. Uranium-230 can also serve as a "parent nuclide" in radionuclide generators, allowing for the periodic separation of thorium-226 and thereby providing a localized supply of short-lived therapeutic radionuclides. However, uranium-230 remains in the research stage regarding production processes, chelation chemistry, and preclinical applications, and a routine commercial market for this medical isotope has not yet been established.
The upstream segment of the industry chain primarily encompasses high-purity thorium-232 metal targets or protactinium-231 targets, medium-to-high-energy proton accelerators, irradiation target stations, hot cells, remote handling equipment, radiation shielding systems, and materials for ion exchange and solvent extraction. One production route with a solid research foundation involves proton irradiation of thorium-232: the ^232Th(p,3n)^230Pa reaction first produces protactinium-230 (half-life ~17.4 days), which then decays into uranium-230. Another route involves proton irradiation of the scarce protactinium-231 target to directly produce uranium-230 via the ^231Pa(p,2n)^230U reaction. The thorium target route offers relatively good raw material availability and potential for co-production with other medical radionuclides like actinium-225; however, it generates fission products as well as other uranium and protactinium isotopes, necessitating highly selective separation processes. Key upstream technical challenges lie in high-energy proton beam technology, the fabrication of radioactive thorium targets, the control of protactinium and uranium impurities, target material recovery, and automated operations within highly radioactive environments. The midstream sector of the industry chain primarily comprises national laboratories, medical isotope production centers, radiochemistry platforms, and radiopharmaceutical R&D institutions; these entities are responsible for rapidly separating Protactinium-230 (Pa-230) and Uranium-230 (U-230) from irradiated thorium targets and converting the products into chemical forms suitable for generator loading or radiolabeling. Publicly available research has established dual-column ion-exchange and extraction chromatography processes capable of simultaneously recovering high-purity U-230 and Pa-230 from proton-irradiated Thorium-232 (Th-232) targets and their fission products. U-230 can be further processed into a U-230/Th-226 generator, utilizing the chemical differences between the two elements to repeatedly separate Thorium-226 (Th-226); such systems have achieved Th-226 separation yields exceeding 96%, delivering the product in a solution form suitable for subsequent chelation reactions. Another core midstream task involves developing chelating agents capable of stably binding uranyl ions in vivo to prevent U-230 from dissociating from its targeting vector and depositing in non-target organs; several multidentate ligands have already demonstrated favorable complexation stability in *in vitro* and animal studies. The downstream sector primarily encompasses oncology radiopharmaceutical developers, nuclear medicine centers, preclinical research institutions, and national nuclear medicine laboratories. U-230 can be directly conjugated to antibodies, peptides, or small-molecule targeting vectors for use as an alpha-emitting therapeutic radionuclide with a relatively long half-life; alternatively, it can serve as the parent isotope in a U-230/Th-226 generator, allowing for the on-demand separation of short-lived Th-226 at hospitals or regional radiopharmacies. The U-230/Th-226 decay chain generates multiple alpha particles in succession, theoretically delivering a high total radiation dose to target cells, which makes it a promising candidate for treating refractory tumors, micrometastases, and residual disease. Its industrialization remains constrained by factors such as the complexity of uranium coordination chemistry, the potential for in vivo migration of daughter nuclides, limited production facilities, insufficient dosimetry data, and the lack of mature GMP manufacturing and regulatory standards; in the short term, demand is primarily driven by research batches and preclinical projects, while the ultimate development of a commercial market depends on stable chelation systems, animal safety profiles, and clinical evidence from human studies.
The surging interest in targeted alpha therapy is the primary driver behind the R&D and industrialization of Uranium-230. Characterized by high linear energy transfer (LET) and a short tissue range, alpha particles induce irreparable DNA double-strand breaks within a localized area, making them particularly suitable for treating micrometors, disseminated lesions, and micrometastases. With a half-life of approximately 20.8 days, Uranium-230 serves both as a potential therapeutic radionuclide and as the parent isotope for Thorium-226; the Uranium-230/Thorium-226 decay chain releases multiple alpha particles, theoretically offering high therapeutic efficacy per unit of radionuclide. Amidst supply shortages and high costs associated with alpha-emitters like Actinium-225, research institutions are evaluating candidates suitable for large-scale production, thereby keeping Uranium-230 in the spotlight. However, its therapeutic value requires further validation through systematic studies on animal efficacy, dosimetry, and toxicology, and it has not yet reached the stage of mature clinical application.
The Uranium-230/Thorium-226 generator model represents its most distinctive application pathway. Thorium-226 has a half-life of only about 30.6 minutes, making long-distance distribution from centralized production facilities impractical; conversely, the longer-lived Uranium-230 can be loaded into a generator to allow for the on-demand separation of Thorium-226 at regional nuclear medicine centers or radiopharmacies. This model—combining the transport of a long-lived parent isotope with the on-site preparation of a short-lived daughter isotope—promises to overcome the supply radius limitations associated with short-lived alpha-emitters while facilitating repeated elutions and continuous research use. Publicly available research has already confirmed the feasibility of separation using the Uranium-230/Thorium-226 generator and has led to the development of rapid elution and "reverse generator" processes; consequently, the industry's focus is likely to shift gradually from the standalone sale of Uranium-230 stock solutions toward generator assemblies, automated separation modules, and supporting quality control services.
Trends on the supply side will center on the co-production of Thorium targets, automated separation technologies, and the scaling up of production. Currently, a practically viable approach involves bombarding Thorium-232 with high-energy protons to first produce Protactinium-230, which then decays into Uranium-230. This route leverages existing medical isotope accelerator facilities and offers the potential for co-production with other thorium-target products—such as Actinium-225—thereby enhancing the overall utilization efficiency of both the proton beam and the target material. Research published in 2024 has established a process for the simultaneous separation of Protactinium-230 and Uranium-230 from proton-irradiated thorium targets and reported high recovery rates, indicating that the technology is advancing from basic feasibility studies toward reproducible batch production.
This Insight Report provides a comprehensive analysis of the global Uranium-230 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Uranium-230 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Uranium-230 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Uranium-230 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Uranium-230.
This report presents a comprehensive overview, market shares, and growth opportunities of Uranium-230 market by product type, application, key manufacturers and key regions and countries.
In 2025, global Uranium-230 production was approximately 43 grams, with an average global market price of around $124,000 per gram. That year, total global production capacity for Uranium-230 reached 120 grams, and the industry's average gross profit margin stood at 35%. Uranium-230 is an artificial radioactive isotope of uranium with an atomic number of 92 and a mass number of 230. It has a half-life of approximately 20.8 days and primarily decays via alpha emission into thorium-226 (which has a half-life of about 30.6 minutes), subsequently releasing multiple alpha particles as it proceeds along the decay chain. Due to the high linear energy transfer and short tissue range of alpha particles, uranium-230 and its daughter isotope, thorium-226, are being investigated for targeted alpha therapy; they are particularly promising for treating micrometastases, residual lesions, and disseminated cancer cells. Uranium-230 can also serve as a "parent nuclide" in radionuclide generators, allowing for the periodic separation of thorium-226 and thereby providing a localized supply of short-lived therapeutic radionuclides. However, uranium-230 remains in the research stage regarding production processes, chelation chemistry, and preclinical applications, and a routine commercial market for this medical isotope has not yet been established.
The upstream segment of the industry chain primarily encompasses high-purity thorium-232 metal targets or protactinium-231 targets, medium-to-high-energy proton accelerators, irradiation target stations, hot cells, remote handling equipment, radiation shielding systems, and materials for ion exchange and solvent extraction. One production route with a solid research foundation involves proton irradiation of thorium-232: the ^232Th(p,3n)^230Pa reaction first produces protactinium-230 (half-life ~17.4 days), which then decays into uranium-230. Another route involves proton irradiation of the scarce protactinium-231 target to directly produce uranium-230 via the ^231Pa(p,2n)^230U reaction. The thorium target route offers relatively good raw material availability and potential for co-production with other medical radionuclides like actinium-225; however, it generates fission products as well as other uranium and protactinium isotopes, necessitating highly selective separation processes. Key upstream technical challenges lie in high-energy proton beam technology, the fabrication of radioactive thorium targets, the control of protactinium and uranium impurities, target material recovery, and automated operations within highly radioactive environments. The midstream sector of the industry chain primarily comprises national laboratories, medical isotope production centers, radiochemistry platforms, and radiopharmaceutical R&D institutions; these entities are responsible for rapidly separating Protactinium-230 (Pa-230) and Uranium-230 (U-230) from irradiated thorium targets and converting the products into chemical forms suitable for generator loading or radiolabeling. Publicly available research has established dual-column ion-exchange and extraction chromatography processes capable of simultaneously recovering high-purity U-230 and Pa-230 from proton-irradiated Thorium-232 (Th-232) targets and their fission products. U-230 can be further processed into a U-230/Th-226 generator, utilizing the chemical differences between the two elements to repeatedly separate Thorium-226 (Th-226); such systems have achieved Th-226 separation yields exceeding 96%, delivering the product in a solution form suitable for subsequent chelation reactions. Another core midstream task involves developing chelating agents capable of stably binding uranyl ions in vivo to prevent U-230 from dissociating from its targeting vector and depositing in non-target organs; several multidentate ligands have already demonstrated favorable complexation stability in *in vitro* and animal studies. The downstream sector primarily encompasses oncology radiopharmaceutical developers, nuclear medicine centers, preclinical research institutions, and national nuclear medicine laboratories. U-230 can be directly conjugated to antibodies, peptides, or small-molecule targeting vectors for use as an alpha-emitting therapeutic radionuclide with a relatively long half-life; alternatively, it can serve as the parent isotope in a U-230/Th-226 generator, allowing for the on-demand separation of short-lived Th-226 at hospitals or regional radiopharmacies. The U-230/Th-226 decay chain generates multiple alpha particles in succession, theoretically delivering a high total radiation dose to target cells, which makes it a promising candidate for treating refractory tumors, micrometastases, and residual disease. Its industrialization remains constrained by factors such as the complexity of uranium coordination chemistry, the potential for in vivo migration of daughter nuclides, limited production facilities, insufficient dosimetry data, and the lack of mature GMP manufacturing and regulatory standards; in the short term, demand is primarily driven by research batches and preclinical projects, while the ultimate development of a commercial market depends on stable chelation systems, animal safety profiles, and clinical evidence from human studies.
The surging interest in targeted alpha therapy is the primary driver behind the R&D and industrialization of Uranium-230. Characterized by high linear energy transfer (LET) and a short tissue range, alpha particles induce irreparable DNA double-strand breaks within a localized area, making them particularly suitable for treating micrometors, disseminated lesions, and micrometastases. With a half-life of approximately 20.8 days, Uranium-230 serves both as a potential therapeutic radionuclide and as the parent isotope for Thorium-226; the Uranium-230/Thorium-226 decay chain releases multiple alpha particles, theoretically offering high therapeutic efficacy per unit of radionuclide. Amidst supply shortages and high costs associated with alpha-emitters like Actinium-225, research institutions are evaluating candidates suitable for large-scale production, thereby keeping Uranium-230 in the spotlight. However, its therapeutic value requires further validation through systematic studies on animal efficacy, dosimetry, and toxicology, and it has not yet reached the stage of mature clinical application.
The Uranium-230/Thorium-226 generator model represents its most distinctive application pathway. Thorium-226 has a half-life of only about 30.6 minutes, making long-distance distribution from centralized production facilities impractical; conversely, the longer-lived Uranium-230 can be loaded into a generator to allow for the on-demand separation of Thorium-226 at regional nuclear medicine centers or radiopharmacies. This model—combining the transport of a long-lived parent isotope with the on-site preparation of a short-lived daughter isotope—promises to overcome the supply radius limitations associated with short-lived alpha-emitters while facilitating repeated elutions and continuous research use. Publicly available research has already confirmed the feasibility of separation using the Uranium-230/Thorium-226 generator and has led to the development of rapid elution and "reverse generator" processes; consequently, the industry's focus is likely to shift gradually from the standalone sale of Uranium-230 stock solutions toward generator assemblies, automated separation modules, and supporting quality control services.
Trends on the supply side will center on the co-production of Thorium targets, automated separation technologies, and the scaling up of production. Currently, a practically viable approach involves bombarding Thorium-232 with high-energy protons to first produce Protactinium-230, which then decays into Uranium-230. This route leverages existing medical isotope accelerator facilities and offers the potential for co-production with other thorium-target products—such as Actinium-225—thereby enhancing the overall utilization efficiency of both the proton beam and the target material. Research published in 2024 has established a process for the simultaneous separation of Protactinium-230 and Uranium-230 from proton-irradiated thorium targets and reported high recovery rates, indicating that the technology is advancing from basic feasibility studies toward reproducible batch production.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Uranium-230 Industry Forecast” looks at past sales and reviews total world Uranium-230 sales in 2025, providing a comprehensive analysis by region and market sector of projected Uranium-230 sales for 2026 through 2032. With Uranium-230 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Uranium-230 industry.This Insight Report provides a comprehensive analysis of the global Uranium-230 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Uranium-230 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Uranium-230 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Uranium-230 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Uranium-230.
This report presents a comprehensive overview, market shares, and growth opportunities of Uranium-230 market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Purity: >95%
- Purity: >98%
Segmentation by Product Form:
- Uranium-230 Stock Solution
- Uranium-230 Radiochemical Intermediate
- Uranium-230/Thorium-226 Generator
Segmentation by Production Route:
- Proton Irradiation of Thorium-232
- Direct Proton Production from Protactinium-231
- Proton Irradiation of Thorium Targets
Segmentation by Quality Grade:
- Nuclear Physics Research Grade
- Preclinical Research Grade
Segmentation by Application:
- Cancer Treatment
- Scientific Research
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- LANL
- NIDC(DOE IP)
- RITVERC JSC
- Uranium
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Uranium-230 market?
- What factors are driving Uranium-230 market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Uranium-230 market opportunities vary by end market size?
- How does Uranium-230 break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Uranium-230 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Uranium-230 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Uranium-230 by Country/Region, 2021, 2025 & 2032
2.2 Uranium-230 Segment by Type
2.2.1 Purity: >95%
2.2.2 Purity: >98%
2.2.3 Uranium-230 Sales by Type
2.2.3.1 Global Uranium-230 Sales Market Share by Type (2021-2026)
2.2.3.2 Global Uranium-230 Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Uranium-230 Sale Price by Type (2021-2026)
2.3 Uranium-230 Segment by Product Form
2.3.1 Uranium-230 Stock Solution
2.3.2 Uranium-230 Radiochemical Intermediate
2.3.3 Uranium-230/Thorium-226 Generator
2.3.4 Uranium-230 Sales by Product Form
2.3.4.1 Global Uranium-230 Sales Market Share by Product Form (2021-2026)
2.3.4.2 Global Uranium-230 Revenue and Market Share by Product Form (2021-2026)
2.3.4.3 Global Uranium-230 Sale Price by Product Form (2021-2026)
2.4 Uranium-230 Segment by Production Route
2.4.1 Proton Irradiation of Thorium-232
2.4.2 Direct Proton Production from Protactinium-231
2.4.3 Proton Irradiation of Thorium Targets
2.4.4 Uranium-230 Sales by Production Route
2.4.4.1 Global Uranium-230 Sales Market Share by Production Route (2021-2026)
2.4.4.2 Global Uranium-230 Revenue and Market Share by Production Route (2021-2026)
2.4.4.3 Global Uranium-230 Sale Price by Production Route (2021-2026)
2.5 Uranium-230 Segment by Quality Grade
2.5.1 Nuclear Physics Research Grade
2.5.2 Preclinical Research Grade
2.5.3 Uranium-230 Sales by Quality Grade
2.5.3.1 Global Uranium-230 Sales Market Share by Quality Grade (2021-2026)
2.5.3.2 Global Uranium-230 Revenue and Market Share by Quality Grade (2021-2026)
2.5.3.3 Global Uranium-230 Sale Price by Quality Grade (2021-2026)
2.6 Uranium-230 Segment by Application
2.6.1 Cancer Treatment
2.6.2 Scientific Research
2.6.3 Uranium-230 Sales by Application
2.6.3.1 Global Uranium-230 Sale Market Share by Application (2021-2026)
2.6.3.2 Global Uranium-230 Revenue and Market Share by Application (2021-2026)
2.6.3.3 Global Uranium-230 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Uranium-230 Breakdown Data by Company
3.1.1 Global Uranium-230 Annual Sales by Company (2021-2026)
3.1.2 Global Uranium-230 Sales Market Share by Company (2021-2026)
3.2 Global Uranium-230 Annual Revenue by Company (2021-2026)
3.2.1 Global Uranium-230 Revenue by Company (2021-2026)
3.2.2 Global Uranium-230 Revenue Market Share by Company (2021-2026)
3.3 Global Uranium-230 Sale Price by Company
3.4 Key Manufacturers Uranium-230 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Uranium-230 Product Location Distribution
3.4.2 Players Uranium-230 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR URANIUM-230 BY GEOGRAPHIC REGION
4.1 World Historic Uranium-230 Market Size by Geographic Region (2021-2026)
4.1.1 Global Uranium-230 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Uranium-230 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Uranium-230 Market Size by Country/Region (2021-2026)
4.2.1 Global Uranium-230 Annual Sales by Country/Region (2021-2026)
4.2.2 Global Uranium-230 Annual Revenue by Country/Region (2021-2026)
4.3 Americas Uranium-230 Sales Growth
4.4 APAC Uranium-230 Sales Growth
4.5 Europe Uranium-230 Sales Growth
4.6 Middle East & Africa Uranium-230 Sales Growth
5 AMERICAS
5.1 Americas Uranium-230 Sales by Country
5.1.1 Americas Uranium-230 Sales by Country (2021-2026)
5.1.2 Americas Uranium-230 Revenue by Country (2021-2026)
5.2 Americas Uranium-230 Sales by Type (2021-2026)
5.3 Americas Uranium-230 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Uranium-230 Sales by Region
6.1.1 APAC Uranium-230 Sales by Region (2021-2026)
6.1.2 APAC Uranium-230 Revenue by Region (2021-2026)
6.2 APAC Uranium-230 Sales by Type (2021-2026)
6.3 APAC Uranium-230 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Uranium-230 by Country
7.1.1 Europe Uranium-230 Sales by Country (2021-2026)
7.1.2 Europe Uranium-230 Revenue by Country (2021-2026)
7.2 Europe Uranium-230 Sales by Type (2021-2026)
7.3 Europe Uranium-230 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Uranium-230 by Country
8.1.1 Middle East & Africa Uranium-230 Sales by Country (2021-2026)
8.1.2 Middle East & Africa Uranium-230 Revenue by Country (2021-2026)
8.2 Middle East & Africa Uranium-230 Sales by Type (2021-2026)
8.3 Middle East & Africa Uranium-230 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Uranium-230
10.3 Manufacturing Process Analysis of Uranium-230
10.4 Industry Chain Structure of Uranium-230
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Uranium-230 Distributors
11.3 Uranium-230 Customer
12 WORLD FORECAST REVIEW FOR URANIUM-230 BY GEOGRAPHIC REGION
12.1 Global Uranium-230 Market Size Forecast by Region
12.1.1 Global Uranium-230 Forecast by Region (2027-2032)
12.1.2 Global Uranium-230 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Uranium-230 Forecast by Type (2027-2032)
12.7 Global Uranium-230 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 LANL
13.1.1 LANL Company Information
13.1.2 LANL Uranium-230 Product Portfolios and Specifications
13.1.3 LANL Uranium-230 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 LANL Main Business Overview
13.1.5 LANL Latest Developments
13.2 NIDC(DOE IP)
13.2.1 NIDC(DOE IP) Company Information
13.2.2 NIDC(DOE IP) Uranium-230 Product Portfolios and Specifications
13.2.3 NIDC(DOE IP) Uranium-230 Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 NIDC(DOE IP) Main Business Overview
13.2.5 NIDC(DOE IP) Latest Developments
13.3 RITVERC JSC
13.3.1 RITVERC JSC Company Information
13.3.2 RITVERC JSC Uranium-230 Product Portfolios and Specifications
13.3.3 RITVERC JSC Uranium-230 Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 RITVERC JSC Main Business Overview
13.3.5 RITVERC JSC Latest Developments
13.4 Uranium
13.4.1 Uranium Company Information
13.4.2 Uranium Uranium-230 Product Portfolios and Specifications
13.4.3 Uranium Uranium-230 Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Uranium Main Business Overview
13.4.5 Uranium Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Uranium-230 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Uranium-230 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Uranium-230 by Country/Region, 2021, 2025 & 2032
2.2 Uranium-230 Segment by Type
2.2.1 Purity: >95%
2.2.2 Purity: >98%
2.2.3 Uranium-230 Sales by Type
2.2.3.1 Global Uranium-230 Sales Market Share by Type (2021-2026)
2.2.3.2 Global Uranium-230 Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Uranium-230 Sale Price by Type (2021-2026)
2.3 Uranium-230 Segment by Product Form
2.3.1 Uranium-230 Stock Solution
2.3.2 Uranium-230 Radiochemical Intermediate
2.3.3 Uranium-230/Thorium-226 Generator
2.3.4 Uranium-230 Sales by Product Form
2.3.4.1 Global Uranium-230 Sales Market Share by Product Form (2021-2026)
2.3.4.2 Global Uranium-230 Revenue and Market Share by Product Form (2021-2026)
2.3.4.3 Global Uranium-230 Sale Price by Product Form (2021-2026)
2.4 Uranium-230 Segment by Production Route
2.4.1 Proton Irradiation of Thorium-232
2.4.2 Direct Proton Production from Protactinium-231
2.4.3 Proton Irradiation of Thorium Targets
2.4.4 Uranium-230 Sales by Production Route
2.4.4.1 Global Uranium-230 Sales Market Share by Production Route (2021-2026)
2.4.4.2 Global Uranium-230 Revenue and Market Share by Production Route (2021-2026)
2.4.4.3 Global Uranium-230 Sale Price by Production Route (2021-2026)
2.5 Uranium-230 Segment by Quality Grade
2.5.1 Nuclear Physics Research Grade
2.5.2 Preclinical Research Grade
2.5.3 Uranium-230 Sales by Quality Grade
2.5.3.1 Global Uranium-230 Sales Market Share by Quality Grade (2021-2026)
2.5.3.2 Global Uranium-230 Revenue and Market Share by Quality Grade (2021-2026)
2.5.3.3 Global Uranium-230 Sale Price by Quality Grade (2021-2026)
2.6 Uranium-230 Segment by Application
2.6.1 Cancer Treatment
2.6.2 Scientific Research
2.6.3 Uranium-230 Sales by Application
2.6.3.1 Global Uranium-230 Sale Market Share by Application (2021-2026)
2.6.3.2 Global Uranium-230 Revenue and Market Share by Application (2021-2026)
2.6.3.3 Global Uranium-230 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Uranium-230 Breakdown Data by Company
3.1.1 Global Uranium-230 Annual Sales by Company (2021-2026)
3.1.2 Global Uranium-230 Sales Market Share by Company (2021-2026)
3.2 Global Uranium-230 Annual Revenue by Company (2021-2026)
3.2.1 Global Uranium-230 Revenue by Company (2021-2026)
3.2.2 Global Uranium-230 Revenue Market Share by Company (2021-2026)
3.3 Global Uranium-230 Sale Price by Company
3.4 Key Manufacturers Uranium-230 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Uranium-230 Product Location Distribution
3.4.2 Players Uranium-230 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR URANIUM-230 BY GEOGRAPHIC REGION
4.1 World Historic Uranium-230 Market Size by Geographic Region (2021-2026)
4.1.1 Global Uranium-230 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Uranium-230 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Uranium-230 Market Size by Country/Region (2021-2026)
4.2.1 Global Uranium-230 Annual Sales by Country/Region (2021-2026)
4.2.2 Global Uranium-230 Annual Revenue by Country/Region (2021-2026)
4.3 Americas Uranium-230 Sales Growth
4.4 APAC Uranium-230 Sales Growth
4.5 Europe Uranium-230 Sales Growth
4.6 Middle East & Africa Uranium-230 Sales Growth
5 AMERICAS
5.1 Americas Uranium-230 Sales by Country
5.1.1 Americas Uranium-230 Sales by Country (2021-2026)
5.1.2 Americas Uranium-230 Revenue by Country (2021-2026)
5.2 Americas Uranium-230 Sales by Type (2021-2026)
5.3 Americas Uranium-230 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Uranium-230 Sales by Region
6.1.1 APAC Uranium-230 Sales by Region (2021-2026)
6.1.2 APAC Uranium-230 Revenue by Region (2021-2026)
6.2 APAC Uranium-230 Sales by Type (2021-2026)
6.3 APAC Uranium-230 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Uranium-230 by Country
7.1.1 Europe Uranium-230 Sales by Country (2021-2026)
7.1.2 Europe Uranium-230 Revenue by Country (2021-2026)
7.2 Europe Uranium-230 Sales by Type (2021-2026)
7.3 Europe Uranium-230 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Uranium-230 by Country
8.1.1 Middle East & Africa Uranium-230 Sales by Country (2021-2026)
8.1.2 Middle East & Africa Uranium-230 Revenue by Country (2021-2026)
8.2 Middle East & Africa Uranium-230 Sales by Type (2021-2026)
8.3 Middle East & Africa Uranium-230 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Uranium-230
10.3 Manufacturing Process Analysis of Uranium-230
10.4 Industry Chain Structure of Uranium-230
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Uranium-230 Distributors
11.3 Uranium-230 Customer
12 WORLD FORECAST REVIEW FOR URANIUM-230 BY GEOGRAPHIC REGION
12.1 Global Uranium-230 Market Size Forecast by Region
12.1.1 Global Uranium-230 Forecast by Region (2027-2032)
12.1.2 Global Uranium-230 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Uranium-230 Forecast by Type (2027-2032)
12.7 Global Uranium-230 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 LANL
13.1.1 LANL Company Information
13.1.2 LANL Uranium-230 Product Portfolios and Specifications
13.1.3 LANL Uranium-230 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 LANL Main Business Overview
13.1.5 LANL Latest Developments
13.2 NIDC(DOE IP)
13.2.1 NIDC(DOE IP) Company Information
13.2.2 NIDC(DOE IP) Uranium-230 Product Portfolios and Specifications
13.2.3 NIDC(DOE IP) Uranium-230 Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 NIDC(DOE IP) Main Business Overview
13.2.5 NIDC(DOE IP) Latest Developments
13.3 RITVERC JSC
13.3.1 RITVERC JSC Company Information
13.3.2 RITVERC JSC Uranium-230 Product Portfolios and Specifications
13.3.3 RITVERC JSC Uranium-230 Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 RITVERC JSC Main Business Overview
13.3.5 RITVERC JSC Latest Developments
13.4 Uranium
13.4.1 Uranium Company Information
13.4.2 Uranium Uranium-230 Product Portfolios and Specifications
13.4.3 Uranium Uranium-230 Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Uranium Main Business Overview
13.4.5 Uranium Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Uranium-230 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Uranium-230 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Purity: >95%
Table 4. Major Players of Purity: >98%
Table 5. Global Uranium-230 Sales by Type (2021-2026) & (Gram)
Table 6. Global Uranium-230 Sales Market Share by Type (2021-2026)
Table 7. Global Uranium-230 Revenue by Type (2021-2026) & ($ million)
Table 8. Global Uranium-230 Revenue Market Share by Type (2021-2026)
Table 9. Global Uranium-230 Sale Price by Type (2021-2026) & (US$/g)
Table 10. Major Players of Uranium-230 Stock Solution
Table 11. Major Players of Uranium-230 Radiochemical Intermediate
Table 12. Major Players of Uranium-230/Thorium-226 Generator
Table 13. Global Uranium-230 Sales by Product Form (2021-2026) & (Gram)
Table 14. Global Uranium-230 Sales Market Share by Product Form (2021-2026)
Table 15. Global Uranium-230 Revenue by Product Form (2021-2026) & ($ million)
Table 16. Global Uranium-230 Revenue Market Share by Product Form (2021-2026)
Table 17. Global Uranium-230 Sale Price by Product Form (2021-2026) & (US$/g)
Table 18. Major Players of Proton Irradiation of Thorium-232
Table 19. Major Players of Direct Proton Production from Protactinium-231
Table 20. Major Players of Proton Irradiation of Thorium Targets
Table 21. Global Uranium-230 Sales by Production Route (2021-2026) & (Gram)
Table 22. Global Uranium-230 Sales Market Share by Production Route (2021-2026)
Table 23. Global Uranium-230 Revenue by Production Route (2021-2026) & ($ million)
Table 24. Global Uranium-230 Revenue Market Share by Production Route (2021-2026)
Table 25. Global Uranium-230 Sale Price by Production Route (2021-2026) & (US$/g)
Table 26. Major Players of Nuclear Physics Research Grade
Table 27. Major Players of Preclinical Research Grade
Table 28. Global Uranium-230 Sales by Quality Grade (2021-2026) & (Gram)
Table 29. Global Uranium-230 Sales Market Share by Quality Grade (2021-2026)
Table 30. Global Uranium-230 Revenue by Quality Grade (2021-2026) & ($ million)
Table 31. Global Uranium-230 Revenue Market Share by Quality Grade (2021-2026)
Table 32. Global Uranium-230 Sale Price by Quality Grade (2021-2026) & (US$/g)
Table 33. Global Uranium-230 Sale by Application (2021-2026) & (Gram)
Table 34. Global Uranium-230 Sale Market Share by Application (2021-2026)
Table 35. Global Uranium-230 Revenue by Application (2021-2026) & ($ million)
Table 36. Global Uranium-230 Revenue Market Share by Application (2021-2026)
Table 37. Global Uranium-230 Sale Price by Application (2021-2026) & (US$/g)
Table 38. Global Uranium-230 Sales by Company (2021-2026) & (Gram)
Table 39. Global Uranium-230 Sales Market Share by Company (2021-2026)
Table 40. Global Uranium-230 Revenue by Company (2021-2026) & ($ millions)
Table 41. Global Uranium-230 Revenue Market Share by Company (2021-2026)
Table 42. Global Uranium-230 Sale Price by Company (2021-2026) & (US$/g)
Table 43. Key Manufacturers Uranium-230 Producing Area Distribution and Sales Area
Table 44. Players Uranium-230 Products Offered
Table 45. Uranium-230 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 46. New Products and Potential Entrants
Table 47. Market M&A Activity & Strategy
Table 48. Global Uranium-230 Sales by Geographic Region (2021-2026) & (Gram)
Table 49. Global Uranium-230 Sales Market Share Geographic Region (2021-2026)
Table 50. Global Uranium-230 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 51. Global Uranium-230 Revenue Market Share by Geographic Region (2021-2026)
Table 52. Global Uranium-230 Sales by Country/Region (2021-2026) & (Gram)
Table 53. Global Uranium-230 Sales Market Share by Country/Region (2021-2026)
Table 54. Global Uranium-230 Revenue by Country/Region (2021-2026) & ($ millions)
Table 55. Global Uranium-230 Revenue Market Share by Country/Region (2021-2026)
Table 56. Americas Uranium-230 Sales by Country (2021-2026) & (Gram)
Table 57. Americas Uranium-230 Sales Market Share by Country (2021-2026)
Table 58. Americas Uranium-230 Revenue by Country (2021-2026) & ($ millions)
Table 59. Americas Uranium-230 Sales by Type (2021-2026) & (Gram)
Table 60. Americas Uranium-230 Sales by Application (2021-2026) & (Gram)
Table 61. APAC Uranium-230 Sales by Region (2021-2026) & (Gram)
Table 62. APAC Uranium-230 Sales Market Share by Region (2021-2026)
Table 63. APAC Uranium-230 Revenue by Region (2021-2026) & ($ millions)
Table 64. APAC Uranium-230 Sales by Type (2021-2026) & (Gram)
Table 65. APAC Uranium-230 Sales by Application (2021-2026) & (Gram)
Table 66. Europe Uranium-230 Sales by Country (2021-2026) & (Gram)
Table 67. Europe Uranium-230 Revenue by Country (2021-2026) & ($ millions)
Table 68. Europe Uranium-230 Sales by Type (2021-2026) & (Gram)
Table 69. Europe Uranium-230 Sales by Application (2021-2026) & (Gram)
Table 70. Middle East & Africa Uranium-230 Sales by Country (2021-2026) & (Gram)
Table 71. Middle East & Africa Uranium-230 Revenue Market Share by Country (2021-2026)
Table 72. Middle East & Africa Uranium-230 Sales by Type (2021-2026) & (Gram)
Table 73. Middle East & Africa Uranium-230 Sales by Application (2021-2026) & (Gram)
Table 74. Key Market Drivers & Growth Opportunities of Uranium-230
Table 75. Key Market Challenges & Risks of Uranium-230
Table 76. Key Industry Trends of Uranium-230
Table 77. Uranium-230 Raw Material
Table 78. Key Suppliers of Raw Materials
Table 79. Uranium-230 Distributors List
Table 80. Uranium-230 Customer List
Table 81. Global Uranium-230 Sales Forecast by Region (2027-2032) & (Gram)
Table 82. Global Uranium-230 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Americas Uranium-230 Sales Forecast by Country (2027-2032) & (Gram)
Table 84. Americas Uranium-230 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. APAC Uranium-230 Sales Forecast by Region (2027-2032) & (Gram)
Table 86. APAC Uranium-230 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 87. Europe Uranium-230 Sales Forecast by Country (2027-2032) & (Gram)
Table 88. Europe Uranium-230 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. Middle East & Africa Uranium-230 Sales Forecast by Country (2027-2032) & (Gram)
Table 90. Middle East & Africa Uranium-230 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 91. Global Uranium-230 Sales Forecast by Type (2027-2032) & (Gram)
Table 92. Global Uranium-230 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 93. Global Uranium-230 Sales Forecast by Application (2027-2032) & (Gram)
Table 94. Global Uranium-230 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 95. LANL Basic Information, Uranium-230 Manufacturing Base, Sales Area and Its Competitors
Table 96. LANL Uranium-230 Product Portfolios and Specifications
Table 97. LANL Uranium-230 Sales (Gram), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 98. LANL Main Business
Table 99. LANL Latest Developments
Table 100. NIDC(DOE IP) Basic Information, Uranium-230 Manufacturing Base, Sales Area and Its Competitors
Table 101. NIDC(DOE IP) Uranium-230 Product Portfolios and Specifications
Table 102. NIDC(DOE IP) Uranium-230 Sales (Gram), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 103. NIDC(DOE IP) Main Business
Table 104. NIDC(DOE IP) Latest Developments
Table 105. RITVERC JSC Basic Information, Uranium-230 Manufacturing Base, Sales Area and Its Competitors
Table 106. RITVERC JSC Uranium-230 Product Portfolios and Specifications
Table 107. RITVERC JSC Uranium-230 Sales (Gram), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 108. RITVERC JSC Main Business
Table 109. RITVERC JSC Latest Developments
Table 110. Uranium Basic Information, Uranium-230 Manufacturing Base, Sales Area and Its Competitors
Table 111. Uranium Uranium-230 Product Portfolios and Specifications
Table 112. Uranium Uranium-230 Sales (Gram), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 113. Uranium Main Business
Table 114. Uranium Latest Developments
Table 1. Uranium-230 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Uranium-230 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Purity: >95%
Table 4. Major Players of Purity: >98%
Table 5. Global Uranium-230 Sales by Type (2021-2026) & (Gram)
Table 6. Global Uranium-230 Sales Market Share by Type (2021-2026)
Table 7. Global Uranium-230 Revenue by Type (2021-2026) & ($ million)
Table 8. Global Uranium-230 Revenue Market Share by Type (2021-2026)
Table 9. Global Uranium-230 Sale Price by Type (2021-2026) & (US$/g)
Table 10. Major Players of Uranium-230 Stock Solution
Table 11. Major Players of Uranium-230 Radiochemical Intermediate
Table 12. Major Players of Uranium-230/Thorium-226 Generator
Table 13. Global Uranium-230 Sales by Product Form (2021-2026) & (Gram)
Table 14. Global Uranium-230 Sales Market Share by Product Form (2021-2026)
Table 15. Global Uranium-230 Revenue by Product Form (2021-2026) & ($ million)
Table 16. Global Uranium-230 Revenue Market Share by Product Form (2021-2026)
Table 17. Global Uranium-230 Sale Price by Product Form (2021-2026) & (US$/g)
Table 18. Major Players of Proton Irradiation of Thorium-232
Table 19. Major Players of Direct Proton Production from Protactinium-231
Table 20. Major Players of Proton Irradiation of Thorium Targets
Table 21. Global Uranium-230 Sales by Production Route (2021-2026) & (Gram)
Table 22. Global Uranium-230 Sales Market Share by Production Route (2021-2026)
Table 23. Global Uranium-230 Revenue by Production Route (2021-2026) & ($ million)
Table 24. Global Uranium-230 Revenue Market Share by Production Route (2021-2026)
Table 25. Global Uranium-230 Sale Price by Production Route (2021-2026) & (US$/g)
Table 26. Major Players of Nuclear Physics Research Grade
Table 27. Major Players of Preclinical Research Grade
Table 28. Global Uranium-230 Sales by Quality Grade (2021-2026) & (Gram)
Table 29. Global Uranium-230 Sales Market Share by Quality Grade (2021-2026)
Table 30. Global Uranium-230 Revenue by Quality Grade (2021-2026) & ($ million)
Table 31. Global Uranium-230 Revenue Market Share by Quality Grade (2021-2026)
Table 32. Global Uranium-230 Sale Price by Quality Grade (2021-2026) & (US$/g)
Table 33. Global Uranium-230 Sale by Application (2021-2026) & (Gram)
Table 34. Global Uranium-230 Sale Market Share by Application (2021-2026)
Table 35. Global Uranium-230 Revenue by Application (2021-2026) & ($ million)
Table 36. Global Uranium-230 Revenue Market Share by Application (2021-2026)
Table 37. Global Uranium-230 Sale Price by Application (2021-2026) & (US$/g)
Table 38. Global Uranium-230 Sales by Company (2021-2026) & (Gram)
Table 39. Global Uranium-230 Sales Market Share by Company (2021-2026)
Table 40. Global Uranium-230 Revenue by Company (2021-2026) & ($ millions)
Table 41. Global Uranium-230 Revenue Market Share by Company (2021-2026)
Table 42. Global Uranium-230 Sale Price by Company (2021-2026) & (US$/g)
Table 43. Key Manufacturers Uranium-230 Producing Area Distribution and Sales Area
Table 44. Players Uranium-230 Products Offered
Table 45. Uranium-230 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 46. New Products and Potential Entrants
Table 47. Market M&A Activity & Strategy
Table 48. Global Uranium-230 Sales by Geographic Region (2021-2026) & (Gram)
Table 49. Global Uranium-230 Sales Market Share Geographic Region (2021-2026)
Table 50. Global Uranium-230 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 51. Global Uranium-230 Revenue Market Share by Geographic Region (2021-2026)
Table 52. Global Uranium-230 Sales by Country/Region (2021-2026) & (Gram)
Table 53. Global Uranium-230 Sales Market Share by Country/Region (2021-2026)
Table 54. Global Uranium-230 Revenue by Country/Region (2021-2026) & ($ millions)
Table 55. Global Uranium-230 Revenue Market Share by Country/Region (2021-2026)
Table 56. Americas Uranium-230 Sales by Country (2021-2026) & (Gram)
Table 57. Americas Uranium-230 Sales Market Share by Country (2021-2026)
Table 58. Americas Uranium-230 Revenue by Country (2021-2026) & ($ millions)
Table 59. Americas Uranium-230 Sales by Type (2021-2026) & (Gram)
Table 60. Americas Uranium-230 Sales by Application (2021-2026) & (Gram)
Table 61. APAC Uranium-230 Sales by Region (2021-2026) & (Gram)
Table 62. APAC Uranium-230 Sales Market Share by Region (2021-2026)
Table 63. APAC Uranium-230 Revenue by Region (2021-2026) & ($ millions)
Table 64. APAC Uranium-230 Sales by Type (2021-2026) & (Gram)
Table 65. APAC Uranium-230 Sales by Application (2021-2026) & (Gram)
Table 66. Europe Uranium-230 Sales by Country (2021-2026) & (Gram)
Table 67. Europe Uranium-230 Revenue by Country (2021-2026) & ($ millions)
Table 68. Europe Uranium-230 Sales by Type (2021-2026) & (Gram)
Table 69. Europe Uranium-230 Sales by Application (2021-2026) & (Gram)
Table 70. Middle East & Africa Uranium-230 Sales by Country (2021-2026) & (Gram)
Table 71. Middle East & Africa Uranium-230 Revenue Market Share by Country (2021-2026)
Table 72. Middle East & Africa Uranium-230 Sales by Type (2021-2026) & (Gram)
Table 73. Middle East & Africa Uranium-230 Sales by Application (2021-2026) & (Gram)
Table 74. Key Market Drivers & Growth Opportunities of Uranium-230
Table 75. Key Market Challenges & Risks of Uranium-230
Table 76. Key Industry Trends of Uranium-230
Table 77. Uranium-230 Raw Material
Table 78. Key Suppliers of Raw Materials
Table 79. Uranium-230 Distributors List
Table 80. Uranium-230 Customer List
Table 81. Global Uranium-230 Sales Forecast by Region (2027-2032) & (Gram)
Table 82. Global Uranium-230 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Americas Uranium-230 Sales Forecast by Country (2027-2032) & (Gram)
Table 84. Americas Uranium-230 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. APAC Uranium-230 Sales Forecast by Region (2027-2032) & (Gram)
Table 86. APAC Uranium-230 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 87. Europe Uranium-230 Sales Forecast by Country (2027-2032) & (Gram)
Table 88. Europe Uranium-230 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. Middle East & Africa Uranium-230 Sales Forecast by Country (2027-2032) & (Gram)
Table 90. Middle East & Africa Uranium-230 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 91. Global Uranium-230 Sales Forecast by Type (2027-2032) & (Gram)
Table 92. Global Uranium-230 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 93. Global Uranium-230 Sales Forecast by Application (2027-2032) & (Gram)
Table 94. Global Uranium-230 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 95. LANL Basic Information, Uranium-230 Manufacturing Base, Sales Area and Its Competitors
Table 96. LANL Uranium-230 Product Portfolios and Specifications
Table 97. LANL Uranium-230 Sales (Gram), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 98. LANL Main Business
Table 99. LANL Latest Developments
Table 100. NIDC(DOE IP) Basic Information, Uranium-230 Manufacturing Base, Sales Area and Its Competitors
Table 101. NIDC(DOE IP) Uranium-230 Product Portfolios and Specifications
Table 102. NIDC(DOE IP) Uranium-230 Sales (Gram), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 103. NIDC(DOE IP) Main Business
Table 104. NIDC(DOE IP) Latest Developments
Table 105. RITVERC JSC Basic Information, Uranium-230 Manufacturing Base, Sales Area and Its Competitors
Table 106. RITVERC JSC Uranium-230 Product Portfolios and Specifications
Table 107. RITVERC JSC Uranium-230 Sales (Gram), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 108. RITVERC JSC Main Business
Table 109. RITVERC JSC Latest Developments
Table 110. Uranium Basic Information, Uranium-230 Manufacturing Base, Sales Area and Its Competitors
Table 111. Uranium Uranium-230 Product Portfolios and Specifications
Table 112. Uranium Uranium-230 Sales (Gram), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 113. Uranium Main Business
Table 114. Uranium Latest Developments
LIST OF FIGURES
Figure 1. Picture of Uranium-230
Figure 2. Uranium-230 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Uranium-230 Sales Growth Rate 2021-2032 (Gram)
Figure 7. Global Uranium-230 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Uranium-230 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Uranium-230 Sales Market Share by Country/Region (2025)
Figure 10. Uranium-230 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Purity: >95%
Figure 12. Product Picture of Purity: >98%
Figure 13. Global Uranium-230 Sales Market Share by Type in 2026
Figure 14. Global Uranium-230 Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Uranium-230 Stock Solution
Figure 16. Product Picture of Uranium-230 Radiochemical Intermediate
Figure 17. Product Picture of Uranium-230/Thorium-226 Generator
Figure 18. Global Uranium-230 Sales Market Share by Product Form in 2026
Figure 19. Global Uranium-230 Revenue Market Share by Product Form (2021-2026)
Figure 20. Product Picture of Proton Irradiation of Thorium-232
Figure 21. Product Picture of Direct Proton Production from Protactinium-231
Figure 22. Product Picture of Proton Irradiation of Thorium Targets
Figure 23. Global Uranium-230 Sales Market Share by Production Route in 2026
Figure 24. Global Uranium-230 Revenue Market Share by Production Route (2021-2026)
Figure 25. Product Picture of Nuclear Physics Research Grade
Figure 26. Product Picture of Preclinical Research Grade
Figure 27. Global Uranium-230 Sales Market Share by Quality Grade in 2026
Figure 28. Global Uranium-230 Revenue Market Share by Quality Grade (2021-2026)
Figure 29. Uranium-230 Consumed in Cancer Treatment
Figure 30. Global Uranium-230 Market: Cancer Treatment (2021-2026) & (Gram)
Figure 31. Uranium-230 Consumed in Scientific Research
Figure 32. Global Uranium-230 Market: Scientific Research (2021-2026) & (Gram)
Figure 33. Global Uranium-230 Sale Market Share by Application (2025)
Figure 34. Global Uranium-230 Revenue Market Share by Application in 2025
Figure 35. Uranium-230 Sales by Company in 2025 (Gram)
Figure 36. Global Uranium-230 Sales Market Share by Company in 2025
Figure 37. Uranium-230 Revenue by Company in 2025 ($ millions)
Figure 38. Global Uranium-230 Revenue Market Share by Company in 2025
Figure 39. Global Uranium-230 Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Uranium-230 Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Uranium-230 Sales 2021-2026 (Gram)
Figure 42. Americas Uranium-230 Revenue 2021-2026 ($ millions)
Figure 43. APAC Uranium-230 Sales 2021-2026 (Gram)
Figure 44. APAC Uranium-230 Revenue 2021-2026 ($ millions)
Figure 45. Europe Uranium-230 Sales 2021-2026 (Gram)
Figure 46. Europe Uranium-230 Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Uranium-230 Sales 2021-2026 (Gram)
Figure 48. Middle East & Africa Uranium-230 Revenue 2021-2026 ($ millions)
Figure 49. Americas Uranium-230 Sales Market Share by Country in 2025
Figure 50. Americas Uranium-230 Revenue Market Share by Country (2021-2026)
Figure 51. Americas Uranium-230 Sales Market Share by Type (2021-2026)
Figure 52. Americas Uranium-230 Sales Market Share by Application (2021-2026)
Figure 53. United States Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Uranium-230 Sales Market Share by Region in 2025
Figure 58. APAC Uranium-230 Revenue Market Share by Region (2021-2026)
Figure 59. APAC Uranium-230 Sales Market Share by Type (2021-2026)
Figure 60. APAC Uranium-230 Sales Market Share by Application (2021-2026)
Figure 61. China Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 65. India Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Uranium-230 Sales Market Share by Country in 2025
Figure 69. Europe Uranium-230 Revenue Market Share by Country (2021-2026)
Figure 70. Europe Uranium-230 Sales Market Share by Type (2021-2026)
Figure 71. Europe Uranium-230 Sales Market Share by Application (2021-2026)
Figure 72. Germany Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 73. France Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Uranium-230 Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Uranium-230 Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Uranium-230 Sales Market Share by Application (2021-2026)
Figure 80. Egypt Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Uranium-230 in 2026
Figure 86. Manufacturing Process Analysis of Uranium-230
Figure 87. Industry Chain Structure of Uranium-230
Figure 88. Channels of Distribution
Figure 89. Global Uranium-230 Sales Market Forecast by Region (2027-2032)
Figure 90. Global Uranium-230 Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Uranium-230 Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Uranium-230 Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Uranium-230 Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Uranium-230 Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Uranium-230
Figure 2. Uranium-230 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Uranium-230 Sales Growth Rate 2021-2032 (Gram)
Figure 7. Global Uranium-230 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Uranium-230 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Uranium-230 Sales Market Share by Country/Region (2025)
Figure 10. Uranium-230 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Purity: >95%
Figure 12. Product Picture of Purity: >98%
Figure 13. Global Uranium-230 Sales Market Share by Type in 2026
Figure 14. Global Uranium-230 Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Uranium-230 Stock Solution
Figure 16. Product Picture of Uranium-230 Radiochemical Intermediate
Figure 17. Product Picture of Uranium-230/Thorium-226 Generator
Figure 18. Global Uranium-230 Sales Market Share by Product Form in 2026
Figure 19. Global Uranium-230 Revenue Market Share by Product Form (2021-2026)
Figure 20. Product Picture of Proton Irradiation of Thorium-232
Figure 21. Product Picture of Direct Proton Production from Protactinium-231
Figure 22. Product Picture of Proton Irradiation of Thorium Targets
Figure 23. Global Uranium-230 Sales Market Share by Production Route in 2026
Figure 24. Global Uranium-230 Revenue Market Share by Production Route (2021-2026)
Figure 25. Product Picture of Nuclear Physics Research Grade
Figure 26. Product Picture of Preclinical Research Grade
Figure 27. Global Uranium-230 Sales Market Share by Quality Grade in 2026
Figure 28. Global Uranium-230 Revenue Market Share by Quality Grade (2021-2026)
Figure 29. Uranium-230 Consumed in Cancer Treatment
Figure 30. Global Uranium-230 Market: Cancer Treatment (2021-2026) & (Gram)
Figure 31. Uranium-230 Consumed in Scientific Research
Figure 32. Global Uranium-230 Market: Scientific Research (2021-2026) & (Gram)
Figure 33. Global Uranium-230 Sale Market Share by Application (2025)
Figure 34. Global Uranium-230 Revenue Market Share by Application in 2025
Figure 35. Uranium-230 Sales by Company in 2025 (Gram)
Figure 36. Global Uranium-230 Sales Market Share by Company in 2025
Figure 37. Uranium-230 Revenue by Company in 2025 ($ millions)
Figure 38. Global Uranium-230 Revenue Market Share by Company in 2025
Figure 39. Global Uranium-230 Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Uranium-230 Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Uranium-230 Sales 2021-2026 (Gram)
Figure 42. Americas Uranium-230 Revenue 2021-2026 ($ millions)
Figure 43. APAC Uranium-230 Sales 2021-2026 (Gram)
Figure 44. APAC Uranium-230 Revenue 2021-2026 ($ millions)
Figure 45. Europe Uranium-230 Sales 2021-2026 (Gram)
Figure 46. Europe Uranium-230 Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Uranium-230 Sales 2021-2026 (Gram)
Figure 48. Middle East & Africa Uranium-230 Revenue 2021-2026 ($ millions)
Figure 49. Americas Uranium-230 Sales Market Share by Country in 2025
Figure 50. Americas Uranium-230 Revenue Market Share by Country (2021-2026)
Figure 51. Americas Uranium-230 Sales Market Share by Type (2021-2026)
Figure 52. Americas Uranium-230 Sales Market Share by Application (2021-2026)
Figure 53. United States Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Uranium-230 Sales Market Share by Region in 2025
Figure 58. APAC Uranium-230 Revenue Market Share by Region (2021-2026)
Figure 59. APAC Uranium-230 Sales Market Share by Type (2021-2026)
Figure 60. APAC Uranium-230 Sales Market Share by Application (2021-2026)
Figure 61. China Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 65. India Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Uranium-230 Sales Market Share by Country in 2025
Figure 69. Europe Uranium-230 Revenue Market Share by Country (2021-2026)
Figure 70. Europe Uranium-230 Sales Market Share by Type (2021-2026)
Figure 71. Europe Uranium-230 Sales Market Share by Application (2021-2026)
Figure 72. Germany Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 73. France Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Uranium-230 Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Uranium-230 Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Uranium-230 Sales Market Share by Application (2021-2026)
Figure 80. Egypt Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Uranium-230 Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Uranium-230 in 2026
Figure 86. Manufacturing Process Analysis of Uranium-230
Figure 87. Industry Chain Structure of Uranium-230
Figure 88. Channels of Distribution
Figure 89. Global Uranium-230 Sales Market Forecast by Region (2027-2032)
Figure 90. Global Uranium-230 Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Uranium-230 Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Uranium-230 Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Uranium-230 Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Uranium-230 Revenue Market Share Forecast by Application (2027-2032)
